Table 3.
Characteristic | Model 1 | Model 2 | ||
---|---|---|---|---|
Coefficient (95% Confidence Interval) | P Value | Coefficient (95% Confidence Interval) | P Value | |
Sex | 11.5 (−13.1 to 36.0) | 0.36 | 2.4 (−1.8 to 6.7) | 0.27 |
Age at PD start | −1.15 (−1.7 to −0.6) | <0.001 | −0.1 (−0.2 to 0.05) | 0.21 |
PD duration | 0.6 (0.2 to 1.0) | 0.003 | 7.10−4 (−0.07 to 0.08) | 0.99 |
Residual Kt/V | 33.6 (11.2 to 56.0) | 0.003 | −0.3 (−4.45 to 3.8) | 0.87 |
β-blocker use | 53.1 (27.7 to 78.5) | <0.001 | 4.2 (−1.1 to 9.5) | 0.12 |
Peritonitis rate | 20.8 (7.7 to 33.9) | 0.002 | 0.4 (−2.8 to 3.6) | 0.24 |
Annual glucose exposure | −9.4×10−5 (−3.1×10−4 to 1.2×10−4) | 0.39 | 1.0×10−5 (−3.5×10−5 to 5.8×10−5) | 0.46 |
Sodium sieving | −186.7 (−340.4 to −33.0) | 0.02 |